JRSIS HEALTH CARE CORPORATION Financials JRSIS Health Care Corporation
Equities
JRSS
US4662802036
Renewable Energy Equipment & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.89 USD | +145.86% |
|
-.--% | +1.14% |
| 04-26 | JRSIS Health Care Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | JRSIS Health Care Corporation Appoints Zhu Linhai as Chief Financial Officer | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 44.63 | 116.8 | 2.19 | 4.238 | 4.459 | 5.136 |
| Enterprise Value (EV) 1 | 69.23 | 134.6 | 19.71 | 27.69 | 4.419 | 6.048 |
| P/E ratio | 22.4 x | 123 x | 0.82 x | 1.9 x | -0.1 x | -840 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.57 x | 3.71 x | 0.06 x | 0.1 x | 50 x | 1.48 x |
| EV / Revenue | 2.44 x | 4.28 x | 0.55 x | 0.62 x | 49.6 x | 1.75 x |
| EV / EBITDA | 7.79 x | 16 x | 2.13 x | 3.15 x | -13.9 x | -44.9 x |
| EV / FCF | -174 x | 17.4 x | -124 x | 26.6 x | -0.99 x | 34.3 x |
| FCF Yield | -0.58% | 5.75% | -0.81% | 3.76% | -101% | 2.92% |
| Price to Book | 3.16 x | 7.89 x | 0.12 x | 0.19 x | 5.5 x | -529 x |
| Nbr of stocks (in thousands) | 1,797 | 1,798 | 1,825 | 1,863 | 5,837 | 5,837 |
| Reference price 2 | 24.83 | 65.00 | 1.200 | 2.275 | 0.7640 | 0.8800 |
| Announcement Date | 01/04/19 | 16/06/20 | 15/04/21 | 15/04/22 | 17/04/23 | 26/04/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 28.4 | 31.46 | 35.71 | 44.39 | 0.0892 | 3.462 |
| EBITDA 1 | 8.891 | 8.434 | 9.244 | 8.798 | -0.3187 | -0.1348 |
| EBIT 1 | 7.126 | 6.222 | 6.548 | 5.484 | -0.3245 | -0.1886 |
| Operating Margin | 25.09% | 19.78% | 18.34% | 12.35% | -363.92% | -5.45% |
| Earnings before Tax (EBT) 1 | 5.613 | 1.926 | 5.197 | 4.37 | -0.3276 | -0.0856 |
| Net income 1 | 1.993 | 0.8881 | 2.679 | 2.232 | -33.72 | -0.0809 |
| Net margin | 7.02% | 2.82% | 7.5% | 5.03% | -37,818.56% | -2.34% |
| EPS 2 | 1.111 | 0.5290 | 1.466 | 1.196 | -7.513 | -0.001047 |
| Free Cash Flow 1 | -0.3989 | 7.736 | -0.1595 | 1.041 | -4.461 | 0.1765 |
| FCF margin | -1.4% | 24.59% | -0.45% | 2.35% | -5,002.9% | 5.1% |
| FCF Conversion (EBITDA) | - | 91.72% | - | 11.84% | - | - |
| FCF Conversion (Net income) | - | 871.11% | - | 46.66% | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 01/04/19 | 16/06/20 | 15/04/21 | 15/04/22 | 17/04/23 | 26/04/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 24.6 | 17.8 | 17.5 | 23.4 | - | 0.91 |
| Net Cash position 1 | - | - | - | - | 0.04 | - |
| Leverage (Debt/EBITDA) | 2.767 x | 2.105 x | 1.895 x | 2.665 x | - | -6.765 x |
| Free Cash Flow 1 | -0.4 | 7.74 | -0.16 | 1.04 | -4.46 | 0.18 |
| ROE (net income / shareholders' equity) | 13.5% | 5.64% | 14.8% | 10.3% | -1.93% | -29.1% |
| ROA (Net income/ Total Assets) | 8.81% | 7.47% | 7.41% | 5.1% | -0.53% | -7.86% |
| Assets 1 | 22.63 | 11.89 | 36.15 | 43.8 | 6,365 | 1.03 |
| Book Value Per Share 2 | 7.870 | 8.240 | 10.40 | 11.80 | 0.1400 | -0 |
| Cash Flow per Share 2 | 0.1400 | 1.100 | 0.4600 | 0.4600 | 0.0100 | 0 |
| Capex 1 | 5.97 | 4.71 | 8.27 | 5.5 | 0.04 | 0 |
| Capex / Sales | 21.01% | 14.98% | 23.17% | 12.39% | 50.07% | 0.04% |
| Announcement Date | 01/04/19 | 16/06/20 | 15/04/21 | 15/04/22 | 17/04/23 | 26/04/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +1.14% | 5.19M | |
| +17.99% | 20.97B | |
| -25.41% | 6.37B | |
| -21.77% | 2.96B | |
| -28.66% | 2.22B | |
| -19.88% | 1.98B | |
| -21.64% | 1.2B | |
| +11.13% | 1.08B | |
| +90.25% | 930M | |
| -8.89% | 920M |
- Stock Market
- Equities
- JRSS Stock
- Financials JRSIS Health Care Corporation
